Literature DB >> 31054092

CPAP adherence and cardiovascular disease: beware of the healthy adherer effect.

Ken M Kunisaki1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31054092      PMCID： PMC6825873          DOI： 10.1007/s11325-019-01849-9

Source DB:  PubMed          Journal:  Sleep Breath        ISSN： 1520-9512            Impact factor:   2.816


× No keyword cloud information.
  4 in total

1.  Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

Authors:  Bradi B Granger; Karl Swedberg; Inger Ekman; Christopher B Granger; Bertil Olofsson; John J V McMurray; Salim Yusuf; Eric L Michelson; Marc A Pfeffer
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

2.  Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.

Authors:  Jeffrey R Curtis; Joseph C Larson; Elizabeth Delzell; Maurice Alan Brookhart; Suzanne M Cadarette; Rowan Chlebowski; Suzanne Judd; Monika Safford; Daniel H Solomon; Andrea Z Lacroix
Journal:  Med Care       Date:  2011-05       Impact factor: 2.983

3.  Adherence to inhaled therapy, mortality and hospital admission in COPD.

Authors:  J Vestbo; J A Anderson; P M A Calverley; B Celli; G T Ferguson; C Jenkins; K Knobil; L R Willits; J C Yates; P W Jones
Journal:  Thorax       Date:  2009-08-23       Impact factor: 9.139

4.  Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients.

Authors:  Minna Myllylä; Anna Hammais; Mikhail Stepanov; Ulla Anttalainen; Tarja Saaresranta; Tarja Laitinen
Journal:  Sleep Breath       Date:  2019-03-08       Impact factor: 2.816
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.